Agency Agreement with Level Biotechnology Inc., Taiwan

Ina Research Inc. (INA) is pleased to announce the signing of an agency agreement with Level Biotechnology Inc. (LBI), a Taiwanese Contract Research Organization.

1.Market Potential
The biopharmaceutical industry in Taiwan is currently growing at an unprecedented rate. With LBI as our locally-based agent, Taiwanese customers can now access INAs services in nonhuman primates, studies which are required as part of the biopharmaceutical development process. In this way, INA hopes to establish a mutually-complementary relationship with LBI, and make inroads into this growing market.

2. About LBI
(1) Company Name: Level Biotechnology Inc.
(2) Address: No. 80, Lane 169, Kangning St., His-Chih Dist., New Taipei City 221, Taiwan R.O.C.
(3) Representative: Chiu Chun-Lung, Chairman/President
(4) Business: Entered into business as a CRO in 2006 with capabilities in rodent, rabbit and dog studies. Strengths in special techniques such as imaging analysis for evaluation of ocular irritation.
(5) Establishment: 1989

3. Date of Agreement
Agency agreement effective as of July 26, 2019.